bluebird bio
BLUE
$0.90
Share price
-0.29%
Change (1 day)
-78.14%
Change (1 year)
bluebird bio (BLUE) - Net assets
Net assets on the balance sheet as of September 2023 : $0.22 B
According to bluebird bio
's latest financial reports the company has $0.22 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
bluebird bio - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.19 B | -47.54% |
| 2021-12-31 | $0.37 B | -72.38% |
| 2020-12-31 | $1.35 B | 5.45% |
| 2019-12-31 | $1.28 B | -31.83% |
| 2018-12-31 | $1.88 B | 16.12% |
| 2017-12-31 | $1.62 B | 86.72% |
| 2016-12-31 | $0.86 B | 2.23% |
| 2015-12-31 | $0.85 B | 73.13% |
| 2014-12-31 | $0.49 B | 223.91% |
| 2013-12-31 | $0.15 B | -372.06% |
| 2012-12-31 | $-55.75 M | 0.07% |
| 2011-12-31 | $-55.71 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $82.20 B | 36,839.37% | 🇫🇷 France |
 Merck MRK | $37.63 B | 16,811.87% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $82.88 M | -62.75% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $38.41 M | -82.74% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 2,125.06% | 🇺🇸 USA |